Skip Navigation


Human Molecular Genetics Advance Access originally published online on April 28, 2009
Human Molecular Genetics 2009 18(14):2575-2583; doi:10.1093/hmg/ddp189
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
18/14/2575    most recent
ddp189v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Khelfaoui, M.
Right arrow Articles by Billuart, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khelfaoui, M.
Right arrow Articles by Billuart, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation

Malik Khelfaoui1,2, Alice Pavlowsky1,2, Andrew D. Powell3, Pamela Valnegri4, Kenneth W. Cheong3, Yann Blandin1,2, Maria Passafaro4, John G.R. Jefferys3, Jamel Chelly1,2 and Pierre Billuart1,2,*

1 Institut Cochin, Université Paris Descartes, CNRS UMR8104, 24 rue du Faubourg Saint Jacques 75014, Paris, France 2 INSERM U567, 22 rue Méchain 75014, Paris, France 3 School of Clinical and Experimental Medicine (Neuroscience), The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 4 DTI- CNR Institute of Neuroscience, 32 via Vanvitelli 20129, Milano, Italy

* To whom correspondence should be addressed. Tel: +33 144412481; Fax: +33 144412421; Email: pierre.billuart{at}inserm.fr or malik.khelfaoui{at}inserm.fr

Received March 2, 2009; Accepted April 21, 2009

The patho-physiological hypothesis of mental retardation caused by the deficiency of the RhoGAP Oligophrenin1 (OPHN1), relies on the well-known functions of Rho GTPases on neuronal morphology, i.e. dendritic spine structure. Here, we describe a new function of this Bin/Amphiphysin/Rvs domain containing protein in the control of clathrin-mediated endocytosis (CME). Through interactions with Src homology 3 domain containing proteins involved in CME, OPHN1 is concentrated to endocytic sites where it down-regulates the RhoA/ROCK signaling pathway and represses the inhibitory function of ROCK on endocytosis. Indeed disruption of Ophn1 in mice reduces the endocytosis of synaptic vesicles and the post-synaptic {alpha}-amino-3-hydroxy-5-methylisoazol-4-propionate (AMPA) receptor internalization, resulting in almost a complete loss of long-term depression in the hippocampus. Finally, pharmacological inhibition of this pathway by ROCK inhibitors fully rescued not only the CME deficit in OPHN1 null cells but also synaptic plasticity in the hippocampus from Ophn1 null model. Altogether, we uncovered a new patho-physiological mechanism for intellectual disabilities associated to mutations in RhoGTPases linked genes and also opened new directions for therapeutic approaches of congenital mental retardation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.